A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

NCT03618797 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

347

Enrollment

INDUSTRY

Sponsor class

Conditions

Complex-dyslipidemia

Interventions

DRUG: HL-PIF cap.160/2mg + Placebo
DRUG: Livalo tab. 2mg + Placebo

Sponsor

Hanlim Pharm. Co., Ltd.